Show simple item record

dc.contributor.authorPurshouse, K
dc.contributor.authorBulbeck, HJ
dc.contributor.authorRooney, AG
dc.contributor.authorNoble, KE
dc.contributor.authorCarruthers, RD
dc.contributor.authorThompson, G
dc.contributor.authorHamerlik, P
dc.contributor.authorYap, C
dc.contributor.authorKurian, KM
dc.contributor.authorJefferies, SJ
dc.contributor.authorLopez, JS
dc.contributor.authorJenkinson, MD
dc.contributor.authorHanemann, CO
dc.contributor.authorStead, LF
dc.date.accessioned2024-04-29T09:58:53Z
dc.date.available2024-04-29T09:58:53Z
dc.date.issued2024-04-11
dc.identifier.issn0305-1846
dc.identifier.issn1365-2990
dc.identifier.otherARTN e12979
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/22330
dc.description.abstract

In 2015, a groundswell of brain tumour patient, carer and charity activism compelled the UK Minister for Life Sciences to form a brain tumour research task and finish group. This resulted, in 2018, with the UK government pledging £20m of funding, to be paralleled with £25m from Cancer Research UK, specifically for neuro-oncology research over the subsequent 5 years. Herein, we review if and how the adult brain tumour research landscape in the United Kingdom has changed over that time and what challenges and bottlenecks remain. We have identified seven universal brain tumour research priorities and three cross-cutting themes, which span the research spectrum from bench to bedside and back again. We discuss the status, challenges and recommendations for each one, specific to the United Kingdom.

dc.format.extente12979-
dc.format.mediumPrint
dc.languageen
dc.publisherWiley
dc.subjectbrain cancer
dc.titleAdult brain tumour research in 2024: Status, challenges and recommendations
dc.typejournal-article
dc.typeReview
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38605644
plymouth.issue2
plymouth.volume50
plymouth.publisher-urlhttp://dx.doi.org/10.1111/nan.12979
plymouth.publication-statusPublished
plymouth.journalNEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
dc.identifier.doi10.1111/nan.12979
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Current Academic staff
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
plymouth.organisational-group|Plymouth|Users by role|Researchers in ResearchFish submission
plymouth.organisational-group|Plymouth|REF 2029 Researchers by UoA
plymouth.organisational-group|Plymouth|REF 2029 Researchers by UoA|UoA01 Clinical Medicine
dc.publisher.placeEngland
dcterms.dateAccepted2024-03-25
dc.date.updated2024-04-29T09:58:51Z
dc.rights.embargodate2024-4-30
dc.identifier.eissn1365-2990
rioxxterms.versionofrecord10.1111/nan.12979


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV